Inventor · name-matched record
TO IRIS TRANTHUYNGAN
1 granted patent·2 pending applications·0 citations·filing 2021–2025
1Inventor score
Technology areasC07K
Files withGENENTECH INC3
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
3 records- 0176US2026055204A1Methods for treatment of cd20-positive proliferative disorder with mosunetuzumab and polatuzumab vedotinGENENTECH INC·Filed 2025·Application pending·0 cites
- 0255US2026078198A1Methods for treating cancer using subcutaneous dosing of mosunetuzumab in combination with polatuzumab vedotinGENENTECH INC·Filed 2025·Application pending·0 cites
- 0345US12516118B2Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies and anti-CD79b antibody drug conjugatesGENENTECH INC·Filed 2021·Granted Jan 6, 2026·0 cites·65 claims
Join the waitlist — get patent alerts
Get an alert when TO IRIS TRANTHUYNGAN files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →